MedTrace Logo

Caffeine, CYPA12 and Resistance Exercise

NCT06610110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-06

No results posted yet for this study

Summary

Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, it remains to be elucidated how CYP1A2 polymorphism influences the acute effects of caffeine on this type of exercise.

Objectives: The present study aims to analyze the effects of acute caffeine intake on muscular strength, power, and endurance performance according to CYP1A2 polymorphism in men and women.

Conditions

  • CYP1A2 Polymorphism
  • Caffeine and Resistance Exercise

Interventions

DIETARY_SUPPLEMENT

Caffeine

Acute caffeine intake (3 mg/kg)

DIETARY_SUPPLEMENT

Placebo

Placebo (3 mg/kg maltodextrin)

Sponsors & Collaborators

  • University of Alcala

    collaborator OTHER

  • Alberto Pérez-López

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-07-30
Completion
2025-07-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06610110 on ClinicalTrials.gov